Skip to content

Elucidation of the protective effect of subcutaneous insulin administration against brain amyloid accumulation

Elucidation of the protective effect of subcutaneous insulin administration against brain amyloid accumulation - Elucidation of the protective effect of subcutaneous insulin administration against brain amyloid accumulation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000059112
Enrollment
12
Registered
2025-09-18
Start date
2025-09-19
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

Type 2 diabetes treated with subcutaneous insulin injections for more than 10 years Patients who have never used subcutaneous insulin injections

Sponsors

Toho university school of medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - Patients with type 2 diabetes who was diagnosed for 10 years or more - Patients aged 65 to 90 years - MOCA-J score of 18 to 25 - Patients who have been receiving subcutaneous insulin injections for 10 years or more - Patients who have never received subcutaneous insulin injections - Patients who have provided written consent to participate in the study

Exclusion criteria

Exclusion criteria: - Patients who have been previously diagnosed with dementia - Patients with underlying conditions that cause cognitive impairment - Heavy alcohol users - Patients taking medications that affect cognitive function - Patients for whom PET scans are difficult to perform - Patients deemed inappropriate by their attending physician

Design outcomes

Primary

MeasureTime frame
The standardized uptake volume ratio (SUVr) was calculated using the volumes of interest (VOI) of eight domain (frontal lobe, parietal lobe, temporal lobe, occipital lobe, posterior cingulate gyrus, precuneus, basal ganglia, and cerebellum) and Composite (a composite of eight regions) and the mean pixel values of Pons, and the mean cortical SUVr (mcSUVr) was compared between insulin user group and noninsulin user group.

Countries

Japan

Contacts

Public ContactFukumi Yoshikawa

Toho university school of medicine Division of Diabetes, Metabolism, and Endocrinology, Department of internal medicine.

fukumi.yoshikawa@med.toho-u.ac.jp0337624151

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026